Change your cover photoUpload Change your cover photoUpload Change your cover photo Daniela Carvalho This user account status is Approved About About Posts Posts Comments Comments Prilenia’s Pridopidine for Huntington’s Disease Accepted for European Marketing Authorisation Review 1 teden ago in: News, Research no comments Chronicle of a Relentless Quest: The Making of a Foundation 1 mesec ago in: Stories no comments IROS, Prilenia and International Huntington’s Disease Association collaborate on first-ever Huntington’s disease (HD) trial in the MENA region 2 mesecev ago in: News no comments uniQure Announces Positive Interim Data Update Demonstrating Slowing of Disease Progression in Phase I/II Trials of AMT-130 for HD 2 mesecev ago in: News, Research no comments Družba Wave Life Sciences napoveduje pozitivne rezultate preskušanja faze 1b/2a SELECT-HD s prvim kliničnim dokazom alelno selektivnega znižanja vrednosti mutiranega huntingtina pri Huntingtonovi bolezni 3 mesecev ago in: News, Research no comments Družba PTC je danes objavila obetavne 12-mesečne rezultate študije faze 2 PIVOT-HD o peroralnem zdravilu PTC518. 3 mesecev ago in: News, Research no comments Študija 2. faze družbe Sage Therapeutics potrjuje kognitivni vpliv Huntingtonove bolezni 3 mesecev ago in: News, Research no comments Novosti z Bližnjega vzhoda in severne Afrike 3 mesecev ago in: News no comments FDA podeljuje podjetju uniQure naziv napredne terapije regenerativne medicine (RMAT) 3 mesecev ago in: News, Research no comments Obstajamo: Tanita Allen pripoveduje o svojem boju za dostop do genetskega testiranja v Združenih državah Amerike 4 mesecev ago in: Stories 1 comment load more posts
Slovenian 
English 
Arabic 
Bulgarian 
Chinese 
Czech 
Danish 
Dutch 
Estonian 
Finnish 
French 
German 
Greek 
Hungarian 
Indonesian 
Italian 
Japanese 
Latvian 
Lithuanian 
Polish 
Portuguese 
Romanian 
Russian 
Slovak 
Spanish 
Swedish 
Turkish 
Ukrainian